Voyager Therapeutics (VYGR) Return on Sales (2016 - 2025)
Historic Return on Sales for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to 2.08%.
- Voyager Therapeutics' Return on Sales fell 17100.0% to 2.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.04%, marking a year-over-year decrease of 42000.0%. This contributed to the annual value of 0.81% for FY2024, which is 13400.0% down from last year.
- Voyager Therapeutics' Return on Sales amounted to 2.08% in Q3 2025, which was down 17100.0% from 6.42% recorded in Q2 2025.
- Voyager Therapeutics' Return on Sales' 5-year high stood at 15.23% during Q4 2022, with a 5-year trough of 32.4% in Q1 2022.
- For the 5-year period, Voyager Therapeutics' Return on Sales averaged around 6.0%, with its median value being 3.93% (2021).
- In the last 5 years, Voyager Therapeutics' Return on Sales plummeted by -284700bps in 2022 and then skyrocketed by 332200bps in 2023.
- Quarter analysis of 5 years shows Voyager Therapeutics' Return on Sales stood at 0.18% in 2021, then surged by 8353bps to 15.23% in 2022, then plummeted by -96bps to 0.63% in 2023, then crashed by -977bps to 5.49% in 2024, then skyrocketed by 62bps to 2.08% in 2025.
- Its last three reported values are 2.08% in Q3 2025, 6.42% for Q2 2025, and 4.77% during Q1 2025.